ATE470677T1 - Peptid zur modulation der caspase-aktivierung - Google Patents

Peptid zur modulation der caspase-aktivierung

Info

Publication number: ATE470677T1
Authority: AT; Austria
Prior art keywords: asp; peptides; structures; fetoprotein; sequences
Prior art date: 2002-10-09

Application number

AT03753618T

Other languages

English (en)

Inventor

Elena Ivanova Dudich

Lidia Nikolaevna Semenkova

Igor Vyacheslavovich Dudich

Eduard Borisovich Tatulov

Dmitry Lvovich Zubov

Timo Kalevi Korpela

Original Assignee

Dudich Elena Ivanovna

Eduard Borisovich Tatulov

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-09

Filing date

2003-10-07

Publication date

2010-06-15

2003-10-07 Application filed by Dudich Elena Ivanovna, Eduard Borisovich Tatulov filed Critical Dudich Elena Ivanovna

2010-06-15 Application granted granted Critical

2010-06-15 Publication of ATE470677T1 publication Critical patent/ATE470677T1/de

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Detergent Compositions (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AT03753618T 2002-10-09 2003-10-07 Peptid zur modulation der caspase-aktivierung ATE470677T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FI20021798A FI118263B (fi)	2002-10-09	2002-10-09	Kaspaasiaktiivisuutta säätelevät peptidit
PCT/FI2003/000735 WO2004033500A1 (en)	2002-10-09	2003-10-07	Peptides modulating caspase activation

Publications (1)

Publication Number	Publication Date
ATE470677T1 true ATE470677T1 (de)	2010-06-15

Family

ID=8564726

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03753618T ATE470677T1 (de)	2002-10-09	2003-10-07	Peptid zur modulation der caspase-aktivierung

Country Status (13)

Country	Link
US (1)	US7446095B2 (de)
EP (1)	EP1558649B1 (de)
JP (1)	JP4446121B2 (de)
CN (1)	CN100551930C (de)
AT (1)	ATE470677T1 (de)
AU (1)	AU2003271784A1 (de)
DE (1)	DE60332950D1 (de)
DK (1)	DK1558649T3 (de)
EA (1)	EA010058B1 (de)
ES (1)	ES2347234T3 (de)
FI (1)	FI118263B (de)
PT (1)	PT1558649E (de)
WO (1)	WO2004033500A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20120135917A1 (en) *	2009-06-16	2012-05-31	Eisaku Yoshihara	Anti-Gram Negative Bacteria Agent
CN101812448B (zh) *	2010-01-15	2011-12-07	浙江大学	一种肝癌靶向双重组凋亡蛋白表达序列及应用
CN102060913B (zh) *	2010-11-30	2012-09-05	暨南大学	一种与人血清白蛋白结合的七肽与应用
EP2970372B1 (de)	2013-03-15	2020-09-30	Celgene Corporation	Modifizierte t-lymphozyten
CN108186666B (zh) *	2018-01-29	2020-02-21	西北大学	一种dna纳米带在抗细胞凋亡上的应用及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1226551B (it) *	1988-07-29	1991-01-24	Sclavo Spa	Peptide sintetico immunologicamente attivo capace di indurre la produzione di anticorpi con elevata specificita' verso l'alfa- fetoproteina e loro impiego in campo diagnostico
AU700975B2 (en) *	1995-01-24	1999-01-14	Merrimack Pharmaceuticals, Inc.	Recombinant human alpha-fetoprotein and uses thereof
AU6887096A (en) *	1996-09-11	1998-04-02	Patrick T. Prendergast	Immune direction therapy
CN1122071C (zh) *	1997-01-16	2003-09-24	三菱化学巴斯夫株式会社	发泡树脂珠粒
JP3816959B2 (ja) *	1997-02-13	2006-08-30	ザリージェンツオブザユニバーシティオブカリフォルニア	肝細胞癌の予防および処置
WO2001015709A1 (en) *	1999-09-02	2001-03-08	Atlantic Biopharmaceuticals, Inc.	USE OF rAFP TO INHIBIT OR PREVENT APOPTOSIS
WO2003007978A1 (en) *	2001-06-02	2003-01-30	Clf Medical Technology Acceleration Program, Inc.	Alpha-fetoprotein peptides and uses thereof

2002
- 2002-10-09 FI FI20021798A patent/FI118263B/fi active IP Right Grant
2003
- 2003-10-07 ES ES03753618T patent/ES2347234T3/es not_active Expired - Lifetime
- 2003-10-07 JP JP2004542524A patent/JP4446121B2/ja not_active Expired - Fee Related
- 2003-10-07 WO PCT/FI2003/000735 patent/WO2004033500A1/en not_active Ceased
- 2003-10-07 AT AT03753618T patent/ATE470677T1/de active
- 2003-10-07 EA EA200500606A patent/EA010058B1/ru not_active IP Right Cessation
- 2003-10-07 AU AU2003271784A patent/AU2003271784A1/en not_active Abandoned
- 2003-10-07 PT PT03753618T patent/PT1558649E/pt unknown
- 2003-10-07 CN CNB2003801011658A patent/CN100551930C/zh not_active Expired - Fee Related
- 2003-10-07 US US10/530,779 patent/US7446095B2/en not_active Expired - Fee Related
- 2003-10-07 DE DE60332950T patent/DE60332950D1/de not_active Expired - Lifetime
- 2003-10-07 DK DK03753618.2T patent/DK1558649T3/da active
- 2003-10-07 EP EP03753618A patent/EP1558649B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
FI20021798A7 (fi)	2004-04-10
AU2003271784A1 (en)	2004-05-04
FI20021798A0 (fi)	2002-10-09
EP1558649B1 (de)	2010-06-09
CN100551930C (zh)	2009-10-21
EA200500606A1 (ru)	2006-06-30
PT1558649E (pt)	2010-09-14
FI118263B (fi)	2007-09-14
US7446095B2 (en)	2008-11-04
CN1703428A (zh)	2005-11-30
JP2006518703A (ja)	2006-08-17
ES2347234T3 (es)	2010-10-27
WO2004033500A1 (en)	2004-04-22
DE60332950D1 (de)	2010-07-22
DK1558649T3 (da)	2010-10-11
JP4446121B2 (ja)	2010-04-07
EA010058B1 (ru)	2008-06-30
EP1558649A1 (de)	2005-08-03
US20060280732A1 (en)	2006-12-14

Similar Documents

Publication	Publication Date	Title
Haug et al.	2016	Discovery of a 9-mer cationic peptide (LTX-315) as a potential first in class oncolytic peptide
Lönn et al.	2015	Cationic PTD/CPP-mediated macromolecular delivery: charging into the cell
MX2023005068A (es)	2023-07-14	Variantes de interleucina-18 y métodos de uso.
Valldorf et al.	2016	An Apoptosis‐Inducing Peptidic Heptad That Efficiently Clusters Death Receptor 5
MX2021006991A (es)	2021-10-13	Ligandos peptidicos biciclicos especificos para metaloproteasa tipo 1 de membrana (mt1-mmp).
PE20080339A1 (es)	2008-06-06	Polipeptidos del factor de coagulacion ix modificados y uso de los mismos para tratamiento
EA202191651A1 (ru)	2021-09-13	Бициклические пептидные лиганды, специфичные к mt1-mmp
DK1745064T3 (da)	2011-04-11	Forbindelser til proteasomenzyminhibering
EA201591766A1 (ru)	2016-02-29	Мутеины интерлейкина-2 для экспансии регуляторных т-клеток
ES2181006T3 (es)	2003-02-16	Uso de amidas de acidos de piridil alcanos, piridil alquenos y/o piridil alquinos en el tratamiento de tumores o en inmunosupresion.
RU2015103816A (ru)	2016-08-27	ПРОНИКАЮЩИЕ В КЛЕТКУ ПЕПТИДЫ, МИШЕНЬЮ КОТОРЫХ ЯВЛЯЕТСЯ eIF4E
WO2006102170A3 (en)	2008-12-18	Recombinant mhc molecules useful for manipulation of antigen-specific t cells
DE60332950D1 (de)	2010-07-22	Peptid zur modulation der caspase-aktivierung
EA200601738A1 (ru)	2007-04-27	Модифицированные белки буганины, цитотоксины и способы их применения
WO2019148194A3 (en)	2019-09-19	Peptidyl inhibitors of calcineurin-nfat interaction
ES2186803T3 (es)	2003-05-16	Peptidos tio-sustituidos como inhibidores de metaloproteinasas y de la liberacion de tnf.
CY1109631T1 (el)	2014-08-13	Χρησιμοποιηση πεπτιδιων, τα οποια εχουν παραχθει απο την αα- ή ββ-αλυσιδα του ανθρωπινου ινωδογονου, για τη θεραπεια σοκ
RU2011110711A (ru)	2012-09-27	Новые биологически активные пептиды и их новое применение
ATE531789T1 (de)	2011-11-15	Zellmembranenveränderung
AR029810A1 (es)	2003-07-16	Metodos y composiciones para la inhibicion de los acontecimientos asociados con la fusion de membrana, incluyendo la transmision de rsv
WO2022023538A3 (en)	2022-03-10	Serum half-life extended pd-l1 inhibitory polypeptides
RU2018118985A (ru)	2020-01-13	Комбинированные лекарственные средства, содержащие модуляторы pkm2 и hmgb1
HRP20040663B1 (hr)	2013-05-31	Peptidi za lijeäśenje raka povezanog s humanim papiloma virusom (hpv) i drugih vrsta epitelnih tumora
EP1161262A4 (de)	2003-05-14	AN DER OBERFLÄCHE VON KARZINOMZELLEN LOKALISIERTES COLLIGIN/HsP47
DE602005024161D1 (de)	2010-11-25	Peptid mit antitumoraler wirkung

Legal Events

Date

Code

Title

Description

2011-07-15

UEP

Publication of translation of european patent specification

Ref document number: 1558649

Country of ref document: EP

2011-10-15

EEIH

Change in the person of patent owner